Literature DB >> 24089040

Characteristics of an outpatient treatment sample by primary substance of abuse.

Aimee N C Campbell1, Edward V Nunes, Erin A McClure, Mei-Chen Hu, Eva Turrigiano, Bruce Goldman, Patricia Q Stabile.   

Abstract

OBJECTIVE: This study examines sociodemographic and clinical characteristics, as a function of primary substance of abuse, among clients approached, screened, and assessed for eligibility in a 10-site effectiveness trial of a Web-based psychosocial intervention for substance use disorders. Consistent with the design of effectiveness trials, eligibility criteria were broad and exclusion criteria minimal; thus, the recruited sample may be viewed as relatively representative of patients seeking treatment throughout the United States.
METHODS: χ tests for categorical variables and F tests for continuous variables were used to analyze demographic, substance use, physical and mental health, and sexual risk data collected at screening and baseline; pairwise comparisons between primary substance subgroups for baseline data were conducted if the test statistic P value was 0.01 or less.
RESULTS: Few participants expressed disinterest in the study at screening because of the computer-assisted intervention. A diverse sample of substance users completed baseline and were enrolled: 22.9% marijuana; 21.7% opiates; 20.9% alcohol; 20.5% cocaine; and 13.9% stimulants users. Marijuana users demonstrated the greatest differences across primary substances: they were younger, less likely to be married or attend 12-step meetings, and more likely to be in treatment as a result of criminal justice involvement. All patients, even marijuana users, reported comparable rates of co-occurring mental health disorders and sexual risk and substantial rates of polysubstance use disorders.
CONCLUSIONS: Primary substance of abuse may be a less important indicator of overall severity compared with co-occurring disorders and other factors common across treatment seekers, further demonstrating the need for integrated treatment services and care and comprehensive pretreatment assessment.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24089040      PMCID: PMC3790139          DOI: 10.1097/ADM.0b013e31829e3971

Source DB:  PubMed          Journal:  J Addict Med        ISSN: 1932-0620            Impact factor:   3.702


  33 in total

1.  EuroQol--a new facility for the measurement of health-related quality of life.

Authors: 
Journal:  Health Policy       Date:  1990-12       Impact factor: 2.980

2.  Patient factors related to early attrition from an outpatient cocaine research clinic.

Authors:  V Agosti; E Nunes; K Ocepeck-Welikson
Journal:  Am J Drug Alcohol Abuse       Date:  1996-02       Impact factor: 3.829

3.  Validation and utility of a self-report version of PRIME-MD: the PHQ primary care study. Primary Care Evaluation of Mental Disorders. Patient Health Questionnaire.

Authors:  R L Spitzer; K Kroenke; J B Williams
Journal:  JAMA       Date:  1999-11-10       Impact factor: 56.272

4.  Predictors of attrition from a national sample of methadone maintenance patients.

Authors:  Michael Mancino; Geoffrey Curran; Xiaotong Han; Elise Allee; Keith Humphreys; Brenda M Booth
Journal:  Am J Drug Alcohol Abuse       Date:  2010-05       Impact factor: 3.829

5.  "I already stopped": abstinence prior to treatment.

Authors:  D B Rosengren; L Downey; D M Donovan
Journal:  Addiction       Date:  2000-01       Impact factor: 6.526

6.  Incentives improve outcome in outpatient behavioral treatment of cocaine dependence.

Authors:  S T Higgins; A J Budney; W K Bickel; F E Foerg; R Donham; G J Badger
Journal:  Arch Gen Psychiatry       Date:  1994-07

7.  The Fagerström Test for Nicotine Dependence: a revision of the Fagerström Tolerance Questionnaire.

Authors:  T F Heatherton; L T Kozlowski; R C Frecker; K O Fagerström
Journal:  Br J Addict       Date:  1991-09

8.  HIV risk-related sex behaviors among injection drug users, crack smokers, and injection drug users who smoke crack.

Authors:  R E Booth; J K Watters; D D Chitwood
Journal:  Am J Public Health       Date:  1993-08       Impact factor: 9.308

9.  Prevalence of marijuana use disorders in the United States: 1991-1992 and 2001-2002.

Authors:  Wilson M Compton; Bridget F Grant; James D Colliver; Meyer D Glantz; Frederick S Stinson
Journal:  JAMA       Date:  2004-05-05       Impact factor: 56.272

10.  The use of the DSM-III-R Checklist for initial diagnostic assessments.

Authors:  J J Hudziak; J E Helzer; M W Wetzel; K B Kessel; B McGee; A Janca; T Przybeck
Journal:  Compr Psychiatry       Date:  1993 Nov-Dec       Impact factor: 3.735

View more
  9 in total

1.  Contingency Management Abstinence Incentives: Cost and Implications for Treatment Tailoring.

Authors:  Colin Cunningham; Maxine Stitzer; Aimee N C Campbell; Martina Pavlicova; Mei-Chen Hu; Edward V Nunes
Journal:  J Subst Abuse Treat       Date:  2015-09-21

2.  Cognitive functioning and treatment outcomes in a randomized controlled trial of internet-delivered drug and alcohol treatment.

Authors:  Matisyahu Shulman; Aimee Campbell; Martina Pavlicova; Mei-Chen Hu; Efrat Aharonovich; Edward V Nunes
Journal:  Am J Addict       Date:  2018-08-09

3.  Cigarette Smoking During Substance Use Disorder Treatment: Secondary Outcomes from a National Drug Abuse Treatment Clinical Trials Network study.

Authors:  Erin A McClure; Aimee N C Campbell; Martina Pavlicova; Meichen Hu; Theresa Winhusen; Ryan G Vandrey; Lesia M Ruglass; Lirio S Covey; Maxine L Stitzer; Tiffany L Kyle; Edward V Nunes
Journal:  J Subst Abuse Treat       Date:  2014-12-30

4.  Gender-based Outcomes and Acceptability of a Computer-assisted Psychosocial Intervention for Substance Use Disorders.

Authors:  Aimee N C Campbell; Edward V Nunes; Martina Pavlicova; Mary Hatch-Maillette; Mei-Chen Hu; Genie L Bailey; Dawn E Sugarman; Gloria M Miele; Traci Rieckmann; Kathy Shores-Wilson; Eva Turrigiano; Shelly F Greenfield
Journal:  J Subst Abuse Treat       Date:  2014-12-30

5.  The Use of Technology in Participant Tracking and Study Retention: Lessons Learned From a Clinical Trials Network Study.

Authors:  Shannon Gwin Mitchell; Robert P Schwartz; Anika A H Alvanzo; Monique S Weisman; Tiffany L Kyle; Eva M Turrigiano; Martha L Gibson; Livangelie Perez; Erin A McClure; Sara Clingerman; Autumn Froias; Danielle R Shandera; Robrina Walker; Dean L Babcock; Genie L Bailey; Gloria M Miele; Lynn E Kunkel; Michael Norton; Maxine L Stitzer
Journal:  Subst Abus       Date:  2015-02-11       Impact factor: 3.716

6.  Neurocognitive Profiling of Adult Treatment Seekers Enrolled in a Clinical Trial of a Web-delivered Intervention for Substance Use Disorders.

Authors:  Efrat Aharonovich; Aimee N C Campbell; Matisyahu Shulman; Mei-Chen Hu; Tiffany Kyle; Theresa Winhusen; Edward V Nunes
Journal:  J Addict Med       Date:  2018 Mar/Apr       Impact factor: 3.702

7.  Internet-delivered treatment for substance abuse: a multisite randomized controlled trial.

Authors:  Aimee N C Campbell; Edward V Nunes; Abigail G Matthews; Maxine Stitzer; Gloria M Miele; Daniel Polsky; Eva Turrigiano; Scott Walters; Erin A McClure; Tiffany L Kyle; Aimee Wahle; Paul Van Veldhuisen; Bruce Goldman; Dean Babcock; Patricia Quinn Stabile; Theresa Winhusen; Udi E Ghitza
Journal:  Am J Psychiatry       Date:  2014-06       Impact factor: 18.112

8.  Substance type moderates the longitudinal association between depression and substance use from pre-treatment through a 1-year follow-up.

Authors:  Deepika Anand; Catherine Paquette; Anna Bartuska; Stacey B Daughters
Journal:  Drug Alcohol Depend       Date:  2019-02-05       Impact factor: 4.492

9.  Clinically relevant characteristics associated with early treatment drug use versus abstinence.

Authors:  Gerald Cochran; Maxine Stitzer; Edward V Nunes; Mei-Chen Hu; Aimee Campbell
Journal:  Addict Sci Clin Pract       Date:  2014-04-04
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.